Development of Cell-Based Assay to Study AAV Vector-Mediated Activation of Innate Immune Responses

被引：0
|
作者：
Baer, Alan [1 ]
Bhattarai, Nirjal [2 ]
机构：
[1] FDA, CBER, Silver Spring, MD USA
[2] FDA, Silver Spring, MD USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1369
引用
收藏
页码：646 / 646
页数：1
相关论文
共 50 条
  • [1] Innate immune responses to adenoviral vector-mediated acute pancreatitis
    Shifrin, AL
    Chirmule, N
    Gao, GP
    Wilson, JM
    Raper, SE
    PANCREAS, 2005, 30 (02) : 122 - 129
  • [2] Developing an In Vitro Assay to Study Innate Immune Responses to AAV Vectors
    Baer, Alan
    Bhattarai, Nirjal
    MOLECULAR THERAPY, 2020, 28 (04) : 521 - 522
  • [3] Viral vector-mediated and cell-based therapies for treatment of cystic fibrosis
    Flotte, Terence R.
    Ng, Philip
    Dylla, Doug E.
    McCray, Paul B., Jr.
    Wang, Guoshun
    Kolls, Jay K.
    Hu, Jim
    MOLECULAR THERAPY, 2007, 15 (02) : 229 - 241
  • [4] Innate immune responses in MS: a systematic monocyte and B cell-based study
    Mathias, Amandine
    Perriard, Guillaume
    Canales, Mathieu
    Soneson, Charlotte
    Delorenzi, Mauro
    Pantaleo, Giuseppe
    Schluep, Myriam
    Du Pasquier, Renaud
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) : 88 - 89
  • [5] Successful AAV vector-mediated gene transfer into canine skeletal muscle required suppression of excess immune responses
    Yuasa, K
    Yoshimura, M
    Urasawa, N
    Sato, K
    Miyagoe-Suzuki, Y
    Howell, JM
    Takeda, S
    MOLECULAR THERAPY, 2004, 9 : S94 - S94
  • [6] Improving AAV in vitro transducibility for cell-based potency assay development
    Girona, G. Estrada
    Georgiadis, A.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A193 - A193
  • [7] Modulation of immune responses in lentiviral vector-mediated gene transfer
    Annoni, Andrea
    Gregori, Silvia
    Naldini, Luigi
    Cantore, Alessio
    CELLULAR IMMUNOLOGY, 2019, 342
  • [8] Development of a Cell-Based AAV9 Vector Potency Assay for the GAN Phase 1 Clinical Trial
    Bailey, Rachel M.
    Zaric, Violeta
    Grieger, Joshua C.
    Samulski, R. Jude
    Gray, Steven J.
    MOLECULAR THERAPY, 2017, 25 (05) : 125 - 126
  • [9] Development of cell-based assay for predictively evaluating the FcγRP-mediated human immune cell activation by therapeutic monoclonal antibodies
    Takakura, Michiko
    Tada, Minoru
    Ishii-Watabe, Akiko
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 485 (01) : 189 - 194
  • [10] Development of Orthogonal Cell-Based Potency Assay to Demonstrate the Biological Effect of AAV Vector-Based Gene Therapy Products
    Kattala, Sree
    Rajanala, Kalpana
    Neupane, Subechhya
    Singh, Dinesh Kumar
    Singh, Pushpendra
    Upadhyay, Arun
    MOLECULAR THERAPY, 2024, 32 (04) : 722 - 723
12345